Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
G.C. Liggins, R.N. Howie.
A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
Pediatrics, 50 (1972), pp. 515-525
[2.]
National Institutes of health Consensus Development Panel.
Effect of corticosteroids for fetal maturation on perinatal outcomes. February 28-March 2, 1994.
Am J Obstet Gynecol, 173 (1995), pp. 246-252
[3.]
B.C. Planer, R.A. Ballard, P.L. Ballard, C.E. Cobum, C. Boardmann, A. Cnaan, et al.
Antenatal corticosteroid (ANCS) use in preterm labor in the USA.
Pediatr Res, 39 (1996), pp. 110A
[4.]
M. Ikegami, D.H. Polk, A.H. Jobe, J. Newnham, P. Sly, R. Koham, et al.
Effect of interval from fetal corticosteroid treatment to delivery on postnatal lung function of preterm lambs.
J Appl Physiol, 80 (1996), pp. 591-597
[5.]
M. Ikegami, A.H. Jobe, J. Newnham, D.H. Polk, K.E. Willet, P. Sly.
Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs.
Am J Respir Crit Care Med, 156 (1997), pp. 178-184
[6.]
A.H. Jobe, N. Wada, L.M. Berry, M. Ikegami, M.G. Ervin.
Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep.
Am J Obstet Gynecol, 178 (1998), pp. 880-885
[7.]
H. Uno, L. Johnmiller, C. Thieme, J.W. Kemnitz, M.J. Engle, E.B. Roecker, et al.
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques.
Dev Brain Res, 53 (1990), pp. 157-167
[8.]
H. French, R. Hagan, S. Evans, M. Godfrey, J. Newnham.
repeated antenatal corticosteroids: Size at birth and subsequent development.
Am J Obstet Gynecol, 180 (1999), pp. 114-121
[9.]
B.A. Banks, A. Cnaan, M.A. Morgan, J.T. Parer, J.D. Merril, P.L. Ballard, et al.
Multiple courses of antenatal corticosteroids and outcome of premature neonates.
Am J Obstet Gynecol, 181 (1999), pp. 709-717
[10.]
M. Esplin, M. Fausett, S. Smith, et al.
Multiple courses of antenatal steroids are associated with a delay in long-term psychomotor development in children with birth weights ≤ 1500 g.
Am J Obstet Gynecol, 182 (2000), pp. 524
[11.]
S.G. Mathews.
Antenatal glucocorticoids and programming of the developing CNS.
Pediatr Res, 47 (2000), pp. 291-300
[12.]
N. Modi, H. Lewis, N. Al-naqeb, M. Ajayi-Obe, C. Doré, M. Rutherford.
The effects of repeated antenatal glucocorticoid therapy on the developing brain.
Pediatr Res, 50 (2001), pp. 581-585
[13.]
D.A. Guinn, M.W. Atkinson, L. Sillivan, M.J. Lee, S. Macgregor, B.V. Parilla, et al.
Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery. A randomized controlled trial.
Jama, 286 (2001), pp. 1581-1587
[14.]
C. McEvoy, S. Bowling, K. Williamson, D. Lozano, L. Tolaymat, L. Izquierdo, et al.
The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: A randomized trial.
Pediatrics, 110 (2002), pp. 280-284
[15.]
National Institutes of Health Consensus Development Panel.
Antenatal corticosteroids revisited: Repeat courses. NIH Consensus development Conference Statement, august 17-18, 2000.
Obstet Gynecol, 98 (2001), pp. 144-150
[16.]
H. Hadad, D. Hsia, S. Gellis.
Studies on respiratory rate in the newborn. Its use in the evaluation of RDS in IDM.
Pediatrics, 17 (1956), pp. 204
[17.]
M. Baden, C.R. Bower, E. Colle, G. Klein, H.W. Tavesch, L. Stern.
A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome.
Pediatrics, 50 (1972), pp. 526
[18.]
P. Groneck, D. Reuss, B. Goetze-Speer, C.P. Speer.
Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of infants at risk for chronic lung disease.
J Pediatr, 122 (1993), pp. 938-944
[19.]
B. Avery, A.B. fletcher, M. Kaplan, D.S. Brudno.
Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia.
Pediatrics, 75 (1985), pp. 106
[20.]
M.C. Mammel, T.P. green, D.E. Johnson, T.R. Thompson.
Controloed trial of examethasone therapy in infants with bronchopulmonary dysplasia.
Lancet, 321 (1983), pp. 1356
[21.]
Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, et-al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants wth respiratory distress syndrome: A multicenter clinical trial. Pediatrics 1997;100(4). URL disponible en: http://www.pediatrics.org/cgi/content/full/100/4/e3
[22.]
H.L. Holliday, R.A. Ehrenkranz, L.W. Doyle.
Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review).
The Cochrane Library, Issue 1,
[23.]
Yeh TF, Lin YJ, Huang ChC, Chen YJ, Lin CH, Lin HC, et al.Early dexamethasone Therapy in Preterm infants: A follow-up study. Pediatrics 1998;101(5) URL disponible en: http://www.pediatrics.org/cgi/content/full/101/5/e7
[24.]
E.S. Shinwell, M. Karplus, D. Reich, Z. Weintzaub, S. Blazer, D. Bader, et al.
Early postnatal dexamethasone treatment ad increased incidence of cerebral palsy Arch Dis Child Fetal Neonatal Ed, 83 (2000), pp. F177-F181
[25.]
C. Romagnoli, E. Zecca, R. Luciano, G. Torrioli, G. Tortorob.
Controlled trial of early dexamethasone for the prevention of chronic lung disease in preterm infants:a 3-year follow-up.
Pediatrics, 109 (2002), pp. 985
[26.]
T.M. O'Shea, J.M. Kothadia, K.L. Klinepeter, D.J. Goldstein, B.G. Jackson, R.G. Weaver, et al.
Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age.
Pediatrics, 104 (1999), pp. 15-21
[27.]
J.J. Cummings, D.B. D'Eugenio, S.J. Gross.
A controlled trial of dexamethasone in preterm infants at hih risk for bonchopulmonary dysplasia.
N Engl J Med, 320 (1989), pp. 1505-1510
[28.]
H.L. Holliday, R.A. Ehrenkranz, L.W. Doyle.
Delayed (> 3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review).
The Cochrane Library, Issue 1,
[29.]
H.L. Holliday, R.A. Ehrenkranz.
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review).
The Cochrane Library, Issue 2,
[30.]
A.R. Stark, W.A. Carlo, J.E. Tyson, L.A. Papile, H.H. Wright, S. Shankaran, et al.
Adverse effects of early dexamethasone treatment in extremely- low-birth-weight infants.
N Engl J Med, 344 (2001), pp. 95-101
[31.]
M. Villa, A. Pellicer, M. Burgueros, J. Quero.
Miocardiopatía hipertrófica en un recién nacido de bajo peso tratado con dexametasona.
An Esp Pediatr, 44 (1996), pp. 393-394
[32.]
J.B. Van Goudoever, J.D.L Wattimena, V.P. Carnielli, E.J. Sulkers, H.J. Degenhart, P.J.J. sauer.
Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia.
J Pediatr, 124 (1994), pp. 112-118
[33.]
M. Cotterell, R. Balazs, A.C. Johnson.
Effects of corticosteroids on the biochemical maturation of rat brain:postnatal cell formation.
J Neurochem, 19 (1972), pp. 2151-2167
[34.]
F. Cabañas, A. Pellicer, A. García-Alix, J. Quero, T.A. Stiris.
The effect of dexamethasone therapy on cerebral and ocular blood flow velocity in premature infants studied by colour Doppler flow imaging.
Eur J Pediatr, 156 (1997), pp. 41-46
[35.]
A. Pellicer, F. Galla, T.A. Stiris, J. Quero, F. Cabañas.
Cerebral haemodynamics in preterm infants after exposure to dexamethasone therapy.
Arch Dis Child Fetal Neonatal Ed, 79 (1998), pp. F123-F128
[36.]
M. Durand, M.E. Mendoza, P. tantivit, A. Kugelman, C. McEvoy.
A randomized trial of moderately early low-dose dexamethasone therapy n very low birth weight infants: Dynamic pulmonary mechanics, oxygenation and ventilation.
Pediatrics, 109 (2002), pp. 262-268
[37.]
K.L. Watterberg, J.S. Gerdes, K.L. Gifford, H.M. Lin.
Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants.
Pediatrics, 104 (1999), pp. 1258-1263
[38.]
H.L. Holliday.
Clinical trials of postnatal corticosteroids: Inhaled and systemic.
Biol Neonate, 76 (1999), pp. 29-40
[39.]
H.L. Holliday, C.C. Patterson.
Halahakoon CWNL, and European Multicenter Steroid Study Group. A Multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: Comparison of early and late treatment and of dexametasone and inhaled budesonide.
Pediatrics, 107 (2001), pp. 232-240
Copyright © 2003. Asociación Española de Pediatría
